Progressive myositis ossificans: genes and variants
Explore variant evidence for Progressive myositis ossificans across 1 analyzed protein (ACVR1). Linked ClinVar records include 9 pathogenic or likely pathogenic variants, 3 variants of uncertain significance and 0 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Progressive myositis ossificans
ACVR1: Activin receptor type-1
It transduces BMP-family signals that regulate bone formation and developmental patterning. Recurrent activating variants cause fibrodysplasia ossificans progressiva by making connective-tissue cells abnormally responsive to osteogenic signaling, and somatic variants also occur in diffuse midline glioma.
9 ClinVar pathogenic / likely pathogenic and 3 uncertain variants in ACVR1 have source records linked to Progressive myositis ossificans. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Progressive myositis ossificans
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| ACVR1 G328E | 328 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| ACVR1 R206H | 206 | GS | Pathogenic / likely pathogenic (★★) |
| ACVR1 G356D | 356 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| ACVR1 R258G | 258 | Protein kinase | Pathogenic / likely pathogenic (★) |
| ACVR1 R258S | 258 | Protein kinase | Pathogenic / likely pathogenic |
| ACVR1 G328W | 328 | Protein kinase | Pathogenic / likely pathogenic |
| ACVR1 L196P | 196 | GS | Pathogenic / likely pathogenic |
| ACVR1 R202I | 202 | GS | Pathogenic / likely pathogenic |
| ACVR1 R375P | 375 | Protein kinase | Pathogenic / likely pathogenic |
Which prediction tools work for Progressive myositis ossificans
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 95 out of 100
- AlphaMissense: 92 out of 100
Diseases related to Progressive myositis ossificans
- Primary myelofibrosis, also linked to ACVR1
Frequently asked questions
Which genes have records linked to Progressive myositis ossificans?
This view contains 1 analyzed proteins: ACVR1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 9 pathogenic or likely pathogenic variants, 3 variants of uncertain significance and 0 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 19 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center